Testing effectiveness (Phase 2)Study completedNCT00700713
What this trial is testing
Antibody Persistence and Booster Dose Response in Subjects Who Received Menactra® Three Years Earlier in Study MTA26
Who this might be right for
MeningitisMeningococcemia
Sanofi Pasteur, a Sanofi Company 181